Vaccination ( 4724 results )
Semaine européenne de la vaccination 2026
- report/summary
(Updated on )
Risk factors for leptospirosis in mainland France. A case-control study, July 1999–February 2000.
Introduction: In France, vaccination against leptospirosis—limited to the Icterohemorrhagiae serogroup—is recommended for professions considered to be at risk of this infection. In...
- report/summary
(Updated on )
Epidemiological Impact of a Change in BCG Vaccination Policy in France: A Literature Review and Analysis of Available Data
The resumption since 1993 of the downward trend in tuberculosis incidence in France calls for a reassessment of the relevance of the BCG vaccination policy. Indeed, the available...
- report/summary
(Updated on )
Measles Surveillance in France. Symposium on February 28, 2001, Saint-Maurice
On February 28, 2001, the French Institute for Public Health Surveillance organized a workshop on measles surveillance in France, attended by the key partners involved in the control...
- conference presentation
(Updated on )
Tuberculosis in France in the Year 2000. Proceedings of the symposium organized by the Association for the Development of Epidemiology in Aquitaine (ADEA) and the Institute of Epidemiology, Public Health, and Development (ISPED), November 17, 2000
While in 2001, one-third of the world’s population was still infected with the tuberculosis bacillus, 95% of cases occurred in the poorest countries on the planet. Yet, since the...
- report/summary
(Updated on )
The Use of the Smallpox Virus as a Biological Weapon: Estimating the Epidemiological Impact and the Role of Vaccination
The World Health Organization declared smallpox eradicated worldwide in 1980, and no new cases have been reported since then. All countries worldwide discontinued smallpox vaccination...
- article
(Updated on )
Outbreak of Tuberculosis in Institutional Settings. Epidemiology and Clinical Features of Tuberculosis Outbreaks in Institutional Settings
- article
(Updated on )
Epidemiology of Tuberculosis
Tuberculosis in France remains a pressing issue. The national incidence rate was 11.2 cases per 100,000 population in 2000 and has remained stable since 1997. The situation is...
- article
(Updated on )
Cases of Hepatitis A in group settings reported to the DDASS: Summary of Investigations and Recommendations
As part of its surveillance and investigation mandate, the French Institute for Public Health Surveillance (InVS) is frequently asked to provide guidance on how to respond to outbreaks...
- article
(Updated on )
Surveillance of Antituberculosis Drug Resistance in Europe, 1999
Natural resistance of Mycobacterium tuberculosis to antituberculosis drugs is rare. Drug resistance results primarily from inappropriate treatment. Resistance to antituberculosis...
- article
(Updated on )
Tetanus in France in 2000 and 2001
Tetanus is an acute infection caused by exotoxins produced by a Gram-positive anaerobic bacterium, Clostridium tetani. The vaccine to prevent this disease, which is virtually 100%...
